Anti-Ionotropic Glutamate receptor 2 antibody [EP966Y]
- 20ul selling size
- RabMAb
- Recombinant
- 각 태그의 뜻
5
(1 리뷰)
|
(11 제품이 사용된 논문 )
- WB
Supplier Data
Western blot - Anti-Ionotropic Glutamate receptor 2 antibody [EP966Y] (AB52932)
Secondary antibody - anti-rabbit HRP (ab6721)
All lanes:
Western blot - Anti-Ionotropic Glutamate receptor 2 antibody [EP966Y] (ab52932) at 1/500 dilution
Lane 1:
Human brain
Lane 2:
Rat brain
Lane 3:
Mouse brain
Predicted band size: 98 kDa
false
- WB
Unknown
Western blot - Anti-Ionotropic Glutamate receptor 2 antibody [EP966Y] (AB52932)
All lanes:
Western blot - Anti-Ionotropic Glutamate receptor 2 antibody [EP966Y] (ab52932) at 1/2000 dilution
All lanes:
Human brain cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP labeled at 1/2000 dilution
Predicted band size: 98 kDa
Observed band size: 110 kDa
false
- WB
CiteAb
Western blot - Anti-Ionotropic Glutamate receptor 2 antibody [EP966Y] (AB52932)
Ionotropic Glutamate receptor 2 western blot using anti-Ionotropic Glutamate receptor 2 antibody [EP966Y] ab52932. Publication image and figure legend from Luo, Y. X., Xue, Y. X., et al., 2015, Nat Commun, PubMed 26169171.
ab52932 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab52932 please see the product overview.
Exposure to UCS decreased membrane expression of GluA1 and GluA2 in BLA.(a) Timeline of the experimental procedure. (b) Membrane expression of GluA1 and GluA2 proteins after the different experiment manipulations. Values are the mean percentage of protein levels in the BLA in reference to the saline+1 h+extinction group. One-way ANOVA, *Different from group 'saline+1 h+extinction', *P<0.05; n=6 per experimental condition. Error bars represent s.e.m. Uncropped western blots of the data depicted in Fig. 5 are provided in Supplementary Fig. 10.
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-Ionotropic Glutamate receptor 2 antibody [EP966Y] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Ion channels like GluR2 contribute to the regulation of synaptic plasticity. GluR2 often forms heteromeric complexes with other AMPA receptor subunits like GluR1 GluR3 and GluR4. These combinations determine the calcium permeability of the receptor complex which has implications for synaptic strength and plasticity. Such properties make GluR2 vital for memory formation and learning given its role in modifying synaptic responses based on neural activity.
Pathways
GluR2 engages significantly in synaptic signaling pathways. It takes part in the AMPA receptor trafficking pathway which dictates its movement to and from the synaptic membrane. GluR2 along with its related proteins like GRIA1 controls the flow of ions that are important for neurotransmission. Another important pathway involving GluR2 is the regulation of excitatory postsynaptic potentials. This function links GluR2 to various cellular processes that respond to neural activity changes.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (11)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Nature communications 14:7971 PubMed38042894
2023
Applications
Unspecified application
Species
Unspecified reactive species
Brain, behavior, and immunity 108:204-220 PubMed36496170
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of stress 18:100453 PubMed35685681
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical pharmacology 180:114136 PubMed32628930
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular psychiatry 22:1274-1281 PubMed28831198
2017
Applications
Unspecified application
Species
Unspecified reactive species
Synapse (New York, N.Y.) 70:471-4 PubMed27262028
2016
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychopharmacology : official publication of 41:2541-56 PubMed27103064
2016
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 6:22096 PubMed26926225
2016
Applications
WB
Species
Rat
Nature communications 6:7675 PubMed26169171
2015
Applications
WB
Species
Rat
Neuropsychopharmacology : official publication of 40:2146-56 PubMed25722116
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com